I agree. After talking to ACTC IR at length, I get the strong impression that the CHA biotech connection in the State of Mass. will garner ACTC a fat funding check, with or without an EO. This will allow them to move some capital around and fulfill their obligations to their multiple teir investors. I think that is the short term game plan. ACTC is also getting money straight from CHA for their blood research, money is coming in from a sale of non-core tech. I also agree that it is in ACTC's best interest to get that stock price up before the end of march so they will have minimal dilution.
All my gut reaction to the little difinitave info IR could tell me. But I feel very strongly that we are experiencing a two front terror campaign put on by the show on the street, and the MM's controlling ACTC. I refuse to take part. I will accumulate here in hopes of averaging down.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.